Dr. Swetha Kambhampati, MD
Claim this profileCity of Hope Medical Center
Area of expertise
Follicular Lymphoma
Swetha Kambhampati, MD has run 4 trials for Follicular Lymphoma. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Swetha Kambhampati, MD has run 3 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
City Of Hope Medical Center
City Of Hope At Irvine Lennar
Clinical Trials Swetha Kambhampati, MD is currently running
Epcoritamab + Tazemetostat
for Follicular Lymphoma
This phase II trial tests the safety, side effects and effectiveness of epcoritamab and tazemetostat in treating patients with grade I-IIIa follicular lymphoma that has come back after a period of improvement (relapsed) or that has not responded to previous treatment (refractory). Epcoritamab is a bispecific monoclonal antibody that binds to two different antigens on the surface of cancer cells that may help the body's immune system attack the cancer and may interfere with the ability of the cancer cells to grow and spread. Tazemetostat, a EZH2 inhibitor, may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving epcoritamab and tazemetostat may be safe, tolerable and/or effective in treating patients with relapsed or refractory grade I-IIIa follicular lymphoma.
Recruiting
1 award
Phase 2
9 criteria
Loncastuximab Tesirine + Mosunetuzumab
for Lymphoma
This phase II trial studies the safety and how well of loncastuximab tesirine when given together with mosunetuzumab works in treating patients with diffuse large B-cell lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Loncastuximab tesirine is a monoclonal antibody, loncastuximab, linked to a toxic agent called tesirine. Loncastuximab attaches to anti-CD19 cancer cells in a targeted way and delivers tesirine to kill them. Mosunetuzumab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Giving loncastuximab tesirine with mosunetuzumab may help treat patients with relapsed or refractory diffuse large B-cell lymphoma.
Recruiting
1 award
Phase 2
More about Swetha Kambhampati, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Swetha Kambhampati, MD has experience with
- Epcoritamab
- Tazemetostat
- Lenalidomide
- Loncastuximab Tesirine
- Mosunetuzumab
- PRO1160
Breakdown of trials Swetha Kambhampati, MD has run
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Lymphoma
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Swetha Kambhampati, MD specialize in?
Swetha Kambhampati, MD focuses on Follicular Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Follicular Lymphoma has involved CD19 positive patients, or patients who are CD20 positive.
Is Swetha Kambhampati, MD currently recruiting for clinical trials?
Yes, Swetha Kambhampati, MD is currently recruiting for 2 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Swetha Kambhampati, MD has studied deeply?
Yes, Swetha Kambhampati, MD has studied treatments such as Epcoritamab, Tazemetostat, Lenalidomide.
What is the best way to schedule an appointment with Swetha Kambhampati, MD?
Apply for one of the trials that Swetha Kambhampati, MD is conducting.
What is the office address of Swetha Kambhampati, MD?
The office of Swetha Kambhampati, MD is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.